149 related articles for article (PubMed ID: 28760097)
21. The Impact of Coverage Restrictions on Antipsychotic Utilization Among Low-Income Medicare Part D Enrollees.
Roberto PN; Brandt N; Onukwugha E; Perfetto E; Powers C; Stuart B
Adm Policy Ment Health; 2017 Nov; 44(6):943-954. PubMed ID: 28660370
[TBL] [Abstract][Full Text] [Related]
22. Changes in drug coverage generosity and untreated serious mental illness: transitioning from Medicaid to Medicare Part D.
Madden JM; Adams AS; LeCates RF; Ross-Degnan D; Zhang F; Huskamp HA; Gilden DM; Soumerai SB
JAMA Psychiatry; 2015 Feb; 72(2):179-88. PubMed ID: 25588123
[TBL] [Abstract][Full Text] [Related]
23. Association between Hospice Spending on Patient Care and Rates of Hospitalization and Medicare Expenditures of Hospice Enrollees.
Aldridge MD; Epstein AJ; Brody AA; Lee EJ; Morrison RS; Bradley EH
J Palliat Med; 2018 Jan; 21(1):55-61. PubMed ID: 28817376
[TBL] [Abstract][Full Text] [Related]
24. Medicaid beneficiaries with congestive heart failure: association of medication adherence with healthcare use and costs.
Esposito D; Bagchi AD; Verdier JM; Bencio DS; Kim MS
Am J Manag Care; 2009 Jul; 15(7):437-45. PubMed ID: 19589011
[TBL] [Abstract][Full Text] [Related]
25. Management of Medicare Part D Prescription Drug Plans and Medication Adherence: A Conceptual Framework and Empirical Analysis.
Young GJ; Rickles NM; Benzer JK; Dangi A
Med Care; 2017 Jan; 55(1):37-42. PubMed ID: 27547952
[TBL] [Abstract][Full Text] [Related]
26. The introduction of generic risperidone in Medicare Part D.
Fung V; Price M; Busch AB; Landrum MB; Fireman B; Nierenberg AA; Newhouse JP; Hsu J
Am J Manag Care; 2016 Jan; 22(1):41-8. PubMed ID: 26799124
[TBL] [Abstract][Full Text] [Related]
27. Assertive community treatment in veterans affairs settings: impact on adherence to antipsychotic medication.
Valenstein M; McCarthy JF; Ganoczy D; Bowersox NW; Dixon LB; Miller R; Visnic S; Slade EP
Psychiatr Serv; 2013 May; 64(5):445-51, 451.e1. PubMed ID: 23412131
[TBL] [Abstract][Full Text] [Related]
28. Associations Between Medicare Part D and Out-of-Pocket Spending, HIV Viral Load, Adherence, and ADAP Use in Dual Eligibles With HIV.
Belenky N; Pence BW; Cole SR; Dusetzina SB; Edmonds A; Oberlander J; Plankey MW; Adedimeji A; Wilson TE; Cohen J; Cohen MH; Milam JE; Golub ET; Adimora AA
Med Care; 2018 Jan; 56(1):47-53. PubMed ID: 29227443
[TBL] [Abstract][Full Text] [Related]
29. Medication use and adherence among elderly Medicare beneficiaries with diabetes enrolled in Part D and retiree health plans.
Stuart B; Simoni-Wastila L; Yin X; Davidoff A; Zuckerman IH; Doshi J
Med Care; 2011 May; 49(5):511-5. PubMed ID: 21422956
[TBL] [Abstract][Full Text] [Related]
30. Impact of oral antipsychotic medication adherence on healthcare resource utilization among schizophrenia patients with Medicare coverage.
Offord S; Lin J; Wong B; Mirski D; Baker RA
Community Ment Health J; 2013 Dec; 49(6):625-9. PubMed ID: 23934237
[TBL] [Abstract][Full Text] [Related]
31. Prospective validation of eight different adherence measures for use with administrative claims data among patients with schizophrenia.
Karve S; Cleves MA; Helm M; Hudson TJ; West DS; Martin BC
Value Health; 2009 Sep; 12(6):989-95. PubMed ID: 19402852
[TBL] [Abstract][Full Text] [Related]
32. Antipsychotic prescription filling in patients with schizophrenia or schizoaffective disorder.
Reutfors J; Brandt L; Stephansson O; Kieler H; Andersen M; Bodén R
J Clin Psychopharmacol; 2013 Dec; 33(6):759-65. PubMed ID: 24126686
[TBL] [Abstract][Full Text] [Related]
33. Impact of provider mailings on medication adherence by Medicare Part D members.
Borah BJ; Qiu Y; Shah ND; Gleason PP
Healthc (Amst); 2016 Sep; 4(3):207-16. PubMed ID: 27637828
[TBL] [Abstract][Full Text] [Related]
34. Medication Adherence, Health Care Utilization, and Spending Among Privately Insured Adults With Chronic Conditions in the United States, 2010-2016.
Gillespie CW; Morin PE; Tucker JM; Purvis L
Am J Med; 2020 Jun; 133(6):690-704.e19. PubMed ID: 31987798
[TBL] [Abstract][Full Text] [Related]
35. Hypertension, cholesterol and diabetes medication adherence, health care utilization and expenditure in a Medicare Supplemental sample.
Campbell PJ; Axon DR; Taylor AM; Smith K; Pickering M; Black H; Warholak T; Chinthammit C
Medicine (Baltimore); 2021 Sep; 100(35):e27143. PubMed ID: 34477169
[TBL] [Abstract][Full Text] [Related]
36. Association of Antihypertensive Medication Adherence With Healthcare Use and Medicaid Expenditures for Acute Cardiovascular Events.
Yang Z; Howard DH; Will J; Loustalot F; Ritchey M; Roy K
Med Care; 2016 May; 54(5):504-11. PubMed ID: 27078823
[TBL] [Abstract][Full Text] [Related]
37. Regions with higher Medicare Part D spending show better drug adherence, but not lower medicare costs for two diseases.
Stuart B; Shoemaker JS; Dai M; Davidoff AJ
Health Aff (Millwood); 2013 Jan; 32(1):120-6. PubMed ID: 23297279
[TBL] [Abstract][Full Text] [Related]
38. Antihypertensive adherence and outcomes among community-dwelling Medicare beneficiaries: the Atherosclerosis Risk in Communities Study.
Federspiel JJ; Sueta CA; Kucharska-Newton AM; Beyhaghi H; Zhou L; Virani SS; Rodgers JE; Chang PP; Stearns SC
J Eval Clin Pract; 2018 Feb; 24(1):48-55. PubMed ID: 27807921
[TBL] [Abstract][Full Text] [Related]
39. The economic impact of Medicare Part D on congestive heart failure.
Dall TM; Blanchard TD; Gallo PD; Semilla AP
Am J Manag Care; 2013 May; 19(6 Suppl):s97-100. PubMed ID: 23725537
[TBL] [Abstract][Full Text] [Related]
40. Review and analysis of hospitalization costs associated with antipsychotic nonadherence in the treatment of schizophrenia in the United States.
Sun SX; Liu GG; Christensen DB; Fu AZ
Curr Med Res Opin; 2007 Oct; 23(10):2305-12. PubMed ID: 17697454
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
